Kontafarma China Holdings Ltd (1312) Stock Statistics & Valuation Metrics

Kontafarma China Holdings Ltd has a market cap or net worth of HKD 150.63M. The enterprise value is HKD 186.41M.

Market Cap

HKD 150.63M

Enterprise Value

HKD 186.41M

Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

5,588,572,000

Owned by Insiders

―

Owned by Institutions

―

Kontafarma China Holdings Ltd’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -33.21%.

Return on Equity (ROE)

-0.77

Return on Assets (ROA)

-0.40

Return on Invested Capital (ROIC)

-33.21%

Return on Capital Employed (ROCE)

-0.40

Revenue Per Employee

1.46M

Profits Per Employee

-684.56K

Employee Count

625

Asset Turnover

0.86

Inventory Turnover

4.41

The current PE Ratio of Kontafarma China Holdings Ltd is -0.71. Kontafarma China Holdings Ltd’s PEG ratio is -0.03.

PE Ratio

-0.71

PS Ratio

0.18

PB Ratio

0.30

Price to FCF

15.74

Price to Operating Cash Flow

5.16

PEG Ratio

-0.03

In the last 12 months, Kontafarma China Holdings Ltd had revenue of 914.71M and earned -427.85M in profits. Earnings per share was -0.08.

Revenue

914.71M

Gross Profit

513.64M

Operating Income

-242.83M

Pretax Income

-454.73M

Net Income

-427.85M

EBITDA

-151.75M

Earnings Per Share (EPS)

-0.08

In the last 12 months, operating cash flow was 29.21M and capital expenditures -19.64M, giving a free cash flow of 9.57M billion.

Operating Cash Flow

29.21M

Free Cash Flow

9.57M

Free Cash Flow per Share

0.00

Kontafarma China Holdings Ltd pays an annual dividend of HKD 0.00, resulting in a dividend yield of ―

Dividend Per Share

HKD 0.00

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

6.35%

Earnings Yield

-141.28%

Beta

0.32

52-Week Price Change

-6.90%

50-Day Moving Average

0.03

200-Day Moving Average

0.03

Relative Strength Index (RSI)

48.24

Average Volume (3m)

1.41M

Kontafarma China Holdings Ltd upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 28, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

May 27, 2013

Kontafarma China Holdings Ltd as a current ratio of 0.79, with Debt / Equity ratio of 36.81%

Current Ratio

0.79

Quick Ratio

0.59

Debt to Market Cap

0.47

Net Debt to EBITDA

-0.91

Interest Coverage Ratio

-22.57

In the past 12 months, Kontafarma China Holdings Ltd has paid 27.83M in taxes.

Income Tax

27.83M

Effective Tax Rate

-0.06

Kontafarma China Holdings Ltd EV to EBITDA ratio is 22.20, with an EV/FCF ratio of 28.50.

EV to Sales

0.32

EV to EBITDA

22.20

EV to Free Cash Flow

28.50

EV to Operating Cash Flow

9.34

Kontafarma China Holdings Ltd has HKD 67.62M in cash and marketable securities with HKD 189.76M in debt, giving a net cash position of -HKD 122.14M billion.

Cash & Marketable Securities

HKD 67.62M

Total Debt

HKD 189.76M

Net Cash

-HKD 122.14M

Net Cash Per Share

-HKD 0.02

Tangible Book Value Per Share

HKD 0.04

Gross margin is 51.79%, with operating margin of -8.34%, and net profit margin of -25.17%.

Gross Margin

51.79%

Operating Margin

-8.34%

Pretax Margin

-22.93%

Net Profit Margin

-25.17%

EBITDA Margin

1.45%

EBIT Margin

-8.34%

The average price target for Kontafarma China Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-5.20%

EPS Growth Forecast

41.38%

Smart Score

7

AI Score

49